2 ms·
Ben Godacre's book Bad Pharma is pretty good. He points out that a large % of this R&D cost is actually marketing. A lot of R&D is also spent on taking existi
by stuaxo 9y ago
Ben Godacre's book Bad Pharma is pretty good.
He points out that a large % of this R&D cost is actually marketing.
A lot of R&D is also spent on taking existing drugs and subtly changing them so that a non-generic one can be launched.
So it's not as cut and dried as it seems.